Karyopharm Therapeutics
Price & Volume
Stats
See more52W Range | $0.56-$10.99 |
Market Cap | $13.7M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $146.6M |
Revenue Growth (YoY) | -11.9% |
Gross Profit (12 Mos) | $145.2M |
Diluted EPS | -$14.33 |
News
See moreYahoo Finance • 2 months ago
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Yahoo Finance • 5 months ago
Karyopharm Therapeutics Q1 Earnings Call Highlights
Yahoo Finance • 6 months ago
RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance
Yahoo Finance • 7 months ago
JPMorgan BetaBuilders MSCI U.S. REIT ETF declares quarterly distribution of $0.4053
About
CEO | Mr. Richard A. Paulson M.B.A. |
CFO | Ms. Lori A. Macomber CPA |
Address | 85 Wells Avenue, Newton, MA, United States, 02459-3298 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 228 |